- Home
- APLT vs IAE Comparison
APLT vs IAE Comparison
Compare APLT & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- IAE
- Stock Information
- Founded
- APLT 2016
- IAE 2007
- Country
- APLT United States
- IAE United States
- Employees
- APLT N/A
- IAE N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- APLT Health Care
- IAE Finance
- Exchange
- APLT Nasdaq
- IAE Nasdaq
- Market Cap
- APLT 37.5M
- IAE 65.2M
- IPO Year
- APLT 2019
- IAE N/A
- Fundamental
- Price
- APLT $0.41
- IAE $6.27
- Analyst Decision
- APLT Buy
- IAE
- Analyst Count
- APLT 7
- IAE 0
- Target Price
- APLT $6.10
- IAE N/A
- AVG Volume (30 Days)
- APLT 1.9M
- IAE 46.3K
- Earning Date
- APLT 05-20-2025
- IAE 01-01-0001
- Dividend Yield
- APLT N/A
- IAE 10.21%
- EPS Growth
- APLT N/A
- IAE N/A
- EPS
- APLT N/A
- IAE N/A
- Revenue
- APLT $455,000.00
- IAE N/A
- Revenue This Year
- APLT $1,768.13
- IAE N/A
- Revenue Next Year
- APLT $361.28
- IAE N/A
- P/E Ratio
- APLT N/A
- IAE N/A
- Revenue Growth
- APLT N/A
- IAE N/A
- 52 Week Low
- APLT $0.30
- IAE $5.31
- 52 Week High
- APLT $10.62
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- APLT 48.67
- IAE 61.01
- Support Level
- APLT $0.39
- IAE $6.19
- Resistance Level
- APLT $0.49
- IAE $6.33
- Average True Range (ATR)
- APLT 0.04
- IAE 0.09
- MACD
- APLT 0.01
- IAE 0.03
- Stochastic Oscillator
- APLT 55.40
- IAE 87.76
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.